國立虎尾科技大學 |

White Coat Hypertension = An Unresolved Diagnostic and Therapeutic Problem /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	White Coat Hypertension/ by Giuseppe Mancia, Guido Grassi, Gianfranco Parati, Alberto Zanchetti.
Reminder of title:	An Unresolved Diagnostic and Therapeutic Problem /
Author:	Mancia, Giuseppe.
other author:	Grassi, Guido.
Description:	VIII, 147 p. 81 illus., 11 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Cardiology. -
Online resource:	https://doi.org/10.1007/978-3-319-07410-8
ISBN:	9783319074108

White Coat Hypertension = An Unresolved Diagnostic and Therapeutic Problem /
Mancia, Giuseppe.

White Coat HypertensionAn Unresolved Diagnostic and Therapeutic Problem /[electronic resource] :by Giuseppe Mancia, Guido Grassi, Gianfranco Parati, Alberto Zanchetti. - 1st ed. 2015. - VIII, 147 p. 81 illus., 11 illus. in color.online resource.

1 Historical Notes -- 2 Definition, Terminology and Prevalence -- 3 Diagnostic Approach to white coat effect and white coat hypertension -- 4 Neurogenic and Non-neurogenic Mechanisms -- 5 Predictive Factors -- 6 White coat hypertension and cardiovascular morbidity and mortality -- 7 White coat hypertension and Target Organ Damage -- 8 White Coat Hypertension, metabolic risk factors, and cardiovascular risk profile -- 9 To Treat or Not To Treat?.

This book addresses all aspects of white coat hypertension – the phenomenon of raised blood pressure in a medical setting yet not elsewhere – from its history to its pathophysiology, diagnosis and treatment. White coat hypertension is a common condition, accounting for 30–40% of the overall hypertensive population. While many studies have addressed this condition, controversy still exists over whether it causes an increased risk to sufferers and should be treated. In the volume neurogenic and non-neurogenic mechanisms are discussed and the significance of various predictive factors, evaluated. The association of white coat hypertension with dysmetabolic risk factors, new-onset diabetes and other conditions is carefully reviewed. Further chapters consider the occurrence of asymptomatic organ damage and cardiovascular outcomes in affected patients, and helpful guidance is also provided on the controversial issue of when to treat and when not to treat. White Coat Hypertension is based largely on work done during the past 30 years by renowned researchers working in Milan, who have made key contributions in improving knowledge of the condition and whose work is well known across the world.

ISBN: 9783319074108

Standard No.: 10.1007/978-3-319-07410-8doiSubjects--Topical Terms:

593957
Cardiology.

LC Class. No.: RC681-688.2

Dewey Class. No.: 616.12

White Coat Hypertension = An Unresolved Diagnostic and Therapeutic Problem /
LDR:03063nam a22003975i 4500 001 967631
003 DE-He213
005 20200701093547.0
007 cr nn 008mamaa
008 201211s2015 gw | s |||| 0|eng d
020 $a 9783319074108 $9 978-3-319-07410-8
024 7 $a 10.1007/978-3-319-07410-8 $2 doi
035 $a 978-3-319-07410-8
050 4 $a RC681-688.2
072 7 $a MJD $2 bicssc
072 7 $a MED010000 $2 bisacsh
072 7 $a MJD $2 thema
082 0 4 $a 616.12 $2 23
100 1 $a Mancia, Giuseppe. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 777973
245 1 0 $a White Coat Hypertension $h [electronic resource] : $b An Unresolved Diagnostic and Therapeutic Problem / $c by Giuseppe Mancia, Guido Grassi, Gianfranco Parati, Alberto Zanchetti.
250 $a 1st ed. 2015.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2015.
300 $a VIII, 147 p. 81 illus., 11 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a 1 Historical Notes -- 2 Definition, Terminology and Prevalence -- 3 Diagnostic Approach to white coat effect and white coat hypertension -- 4 Neurogenic and Non-neurogenic Mechanisms -- 5 Predictive Factors -- 6 White coat hypertension and cardiovascular morbidity and mortality -- 7 White coat hypertension and Target Organ Damage -- 8 White Coat Hypertension, metabolic risk factors, and cardiovascular risk profile -- 9 To Treat or Not To Treat?.
520 $a This book addresses all aspects of white coat hypertension – the phenomenon of raised blood pressure in a medical setting yet not elsewhere – from its history to its pathophysiology, diagnosis and treatment. White coat hypertension is a common condition, accounting for 30–40% of the overall hypertensive population. While many studies have addressed this condition, controversy still exists over whether it causes an increased risk to sufferers and should be treated. In the volume neurogenic and non-neurogenic mechanisms are discussed and the significance of various predictive factors, evaluated. The association of white coat hypertension with dysmetabolic risk factors, new-onset diabetes and other conditions is carefully reviewed. Further chapters consider the occurrence of asymptomatic organ damage and cardiovascular outcomes in affected patients, and helpful guidance is also provided on the controversial issue of when to treat and when not to treat. White Coat Hypertension is based largely on work done during the past 30 years by renowned researchers working in Milan, who have made key contributions in improving knowledge of the condition and whose work is well known across the world.
650 0 $a Cardiology. $3 593957
650 0 $a Diabetes. $3 582755
700 1 $a Grassi, Guido. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 777974
700 1 $a Parati, Gianfranco. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1211369
700 1 $a Zanchetti, Alberto. $e author. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1263286
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319074115
776 0 8 $i Printed edition: $z 9783319074092
776 0 8 $i Printed edition: $z 9783319348162
856 4 0 $u https://doi.org/10.1007/978-3-319-07410-8
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)